Candida Vaginitis
Find comprehensive information on Candida Vaginitis, also known as Vulvovaginal Candidiasis or yeast infection. This resource covers diagnosis codes, clinical documentation tips for healthcare professionals, and treatment options for Candida albicans. Learn about symptoms, differential diagnosis, and best practices for accurate medical coding related to vaginal yeast infections. Explore resources for effective patient care and improved clinical outcomes in women's health.
Fungal infection of the vagina and vulva caused by Candida species, typically Candida albicans.
Itching, burning, thick white discharge, redness, swelling, painful urination, dyspareunia.
Outpatient clinics, womens health, telehealth, primary care, urgent care.
ICD-10 Code Families
Complete code families applicable to B37.3
When to use each related code
| Description | When to use |
|---|---|
| Yeast infection of the vagina. | Vaginal itching, burning, discharge. Consider in women with diabetes or recent antibiotic use. |
| Bacterial overgrowth in the vagina. | Vaginal discharge with fishy odor, often with elevated pH. Common in sexually active women. |
| Inflammation of the vagina, cause often unclear. | Vaginal discomfort, discharge, burning, itching. Exclude other causes like Candida or BV. |
Best-practice checklist
- ✓Document patient-reported symptoms (e.g., itching, discharge)
- ✓Describe characteristics of discharge (e.g., thick, white, curd-like)
- ✓Note presence/absence of vulvar erythema, edema, or fissures
- ✓Record results of KOH wet mount or other diagnostic tests
- ✓Document treatment plan, including medication and dosage
Common pitfalls to avoid
Coding Candida vaginitis without specifying the causative organism (e.g., albicans) can lead to rejected claims or lower reimbursement.
Documenting symptoms inconsistent with Candida vaginitis may trigger audits for medical necessity and coding accuracy.
Coding Candida vaginitis based on presumptive diagnosis without confirmatory lab tests can raise compliance concerns during audits.
Best-practice tips
- 01Avoid excessive sugar intake. ICD-10: B37.3, SNOMED CT: 78249001
- 02Wear breathable cotton underwear. Improve CDI for accurate coding.
- 03Limit douching, maintain healthy vaginal pH. Ensure healthcare compliance.
- 04Probiotic use may prevent recurrence. Optimize clinical documentation.
- 05Topical antifungals per MD guidance. Adhere to compliance guidelines.
Step-by-step checklist
- 1
Confirm thick, white, cottage cheese-like discharge (ICD-10 N87.5, B37.3)
- 2
Patient reports vulvovaginal itching, burning, or soreness (SNOMED CT 410882004)
- 3
Visual exam shows vulvar erythema and edema (document severity)
- 4
Microscopic exam with KOH prep reveals pseudohyphae or budding yeast (ensure quality control)
Ready-to-paste narrative
Patient presents with complaints consistent with vulvovaginal candidiasis, also known as a yeast infection. She reports vulvar pruritus, burning, and thick, white, cottage cheese-like vaginal discharge. Symptoms onset occurred approximately three days ago. She denies fever, chills, abdominal pain, or abnormal vaginal bleeding. Patient reports recent antibiotic use for a sinus infection. Physical examination reveals erythema and edema of the vulva and perineum. Speculum examination confirms thick, white discharge adherent to the vaginal walls. A wet mount preparation with potassium hydroxide reveals pseudohyphae and budding yeast, confirming the diagnosis of Candida vaginitis. Differential diagnoses considered included bacterial vaginosis and trichomoniasis. Treatment plan includes fluconazole 150mg oral tablet, single dose. Patient education provided on proper hygiene practices and risk factors for recurrent yeast infections, including antibiotic use, diabetes, and hormonal changes. Follow-up recommended if symptoms do not resolve within one week. ICD-10 code B37.3, Candidiasis of vulva and vagina, assigned.
Common questions and answers
What are the most reliable diagnostic criteria for recurrent vulvovaginal candidiasis (RVVC) in clinical practice?+
Diagnosing recurrent vulvovaginal candidiasis (RVVC), defined as four or more episodes in one year, requires a multifaceted approach. While a positive vaginal culture for Candida species is the gold standard, it's not always practical in a busy clinical setting. Clinicians should consider a combination of patient-reported symptoms (pruritus, burning, abnormal discharge) along with a pelvic exam showing vulvovaginal erythema, edema, or fissures. Microscopic examination of vaginal secretions with potassium hydroxide (KOH) or Gram stain revealing pseudohyphae or budding yeast can further support the diagnosis. Explore how incorporating a standardized patient symptom questionnaire can enhance the diagnostic accuracy and improve patient communication in cases of suspected RVVC. Consider implementing a diagnostic algorithm for RVVC that includes risk factor assessment (e.g., antibiotic use, uncontrolled diabetes) for improved patient management. Learn more about the emerging diagnostic tools for RVVC, such as PCR-based assays, which offer enhanced sensitivity and specificity compared to traditional methods.
How to differentiate Candida vaginitis from other vulvovaginal infections like bacterial vaginosis or Trichomoniasis in a primary care setting?+
Differentiating Candida vaginitis from other common vulvovaginal infections like bacterial vaginosis (BV) or Trichomoniasis requires careful consideration of clinical presentation and diagnostic testing. While all three can present with vaginal discharge, pruritus, and irritation, some key distinctions exist. Candida vaginitis typically presents with thick, white, "cottage cheese-like" discharge, while BV often has a thin, grayish discharge with a characteristic "fishy" odor. Trichomoniasis, on the other hand, can manifest as a frothy, yellow-green discharge. Point-of-care testing, such as vaginal pH measurement (elevated in BV and Trichomoniasis, normal in Candida), whiff test (positive in BV), and wet mount microscopy (clue cells in BV, motile trichomonads in Trichomoniasis, yeast or pseudohyphae in Candida), can aid in rapid differential diagnosis. Consider implementing a syndromic approach to vulvovaginal infections using validated diagnostic algorithms to ensure accurate and timely treatment. Explore how using a combination of clinical findings and point-of-care tests can minimize reliance on empiric therapy and improve patient outcomes. Learn more about the latest CDC guidelines for managing sexually transmitted infections, including Trichomoniasis.
What are the evidence-based best practices for managing complicated and recurrent Candida vaginitis in patients with underlying comorbidities?+
Managing complicated and recurrent Candida vaginitis, especially in patients with underlying comorbidities like diabetes or immunosuppression, necessitates a personalized and comprehensive approach. Initial treatment for complicated VVC usually involves longer courses of topical or oral antifungal agents (e.g., fluconazole). For recurrent VVC, maintenance antifungal therapy for 6-12 months is often recommended. It is crucial to address any underlying predisposing factors, such as uncontrolled blood sugar levels in diabetic patients or optimizing immune function in immunocompromised individuals. Non-pharmacological interventions like avoiding tight-fitting clothing, maintaining good hygiene practices, and using probiotics may offer additional benefits. Explore how individualized treatment plans considering patient-specific factors and comorbidities can optimize outcomes. Consider implementing a collaborative care model involving specialists like endocrinologists or immunologists for patients with complex cases. Learn more about the emerging research on antifungal resistance and alternative treatment strategies for refractory Candida vaginitis.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.